Rare disease drugmakers seek exclusion from Medicare pricing plans
WASHINGTON — Biotech companies are lobbying the Trump administration to exclude treatments for rare diseases from programs that…
Novo Nordisk sues Eli Lilly over GLP-1 ads
Photo illustration of a group of weight loss medications on a white background. Ucg | Universal Images Group…
What to know about testosterone replacement therapy
US Secretary of Defense Pete Hegseth speaks during a press briefing at the Pentagon in Washington, DC, on…
Ozempic for cats? GLP-1 weight-loss drugs are coming for your fat pet
A beautiful, but over weight Maine Coon Cat gets measured around the belly by a vet. Ryersonclark |…
Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditions
AtaiBeckley’s lead program, BPL-003, is designed to provide durable relief from treatment-resistant depression Acquisition expands Lilly’s neuroscience pipeline…
UnitedHealth Group (UNH) earnings Q2 2026
UnitedHealth Group on Thursday posted second-quarter earnings that blew past estimates and raised its full-year profit outlook, as…
Revolution Medicines, Sanofi, Biogen, SSRIs: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
New genetic reference map accelerates human stem cell research
A team led by bioengineers at the University of California San Diego has developed a genome-scale reference map…
Engineered ribozyme repairs broken RNA to explain origins of life
In most modern cells, DNA stores the genetic blueprint, and relies on proteins to replicate, repair and build…
Large language models are powerful electronic health record encoders
EHRSHOT database and prediction task The EHR data used in our experiments are from the EHRSHOT benchmark for…
GLP-1 implant from Vivani Medical aims to help patients stay on treatment
Michael Siluk | UCG | Universal Images Group | Getty Images Losing weight with GLP-1 drugs is only…
Roche, Eli Lilly, Novo, gene therapy, Hansoh: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…